Sanofi Aventis France
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- LANZOR gastro-resistant capsule, hard 30 mg
- B01 - Agentes antitrombóticos
- CLEXANE PREFILLED SYRINGE solution for injection 20 mg/0.2 ml
- CLEXANE PREFILLED SYRINGE solution for injection 40 mg/0.4 ml
- CLEXANE PREFILLED SYRINGE solution for injection 60 mg/0.6 ml
- CLEXANE PREFILLED SYRINGE solution for injection 80 mg/0.8 ml
- J01 - Antibacterianos para uso sistémico
- ORELOX film-coated tablet 100 mg
- L02 - Terapia endocrina
- ANANDRON tablet 50 mg
- L03 - Inmunoestimulantes
- GRANOCYTE powder and solvent for solution for injection 33.6 M IU (263 µg)+1 ml